top of page
Your Next Generation
Radiopharmaceutical
Platform
BEHIND THE SCIENCE
A company that is led by a seasoned management team with deep expertise
in oncology and radiopharmacuticals
Michael Zalutsky, PhD
CSO, Professor Radiology,
Duke University
Martin Pomper, MD, PhD
Senior Director of Translation
Chair Radiology, University Texas
at South Western
The leader in utilizing the next generation Alpha-Emitter Astatine
-
Ideal nuclear decay scheme for clinical efficacy and safety with one alpha-particle per Astatine-211 decay
-
Abundant polonium x-rays for direct clinical imaging
-
Short 7.2 hour half-life ideal for patient/hospital/production safety
-
Properties similar to iodine so ideal for conjugation for large AND small molecules
BLUE CHIP INVESTORS
bottom of page